Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Table 2.
Influenza vaccine schedule
| Age group | Dose (mL) | No. doses |
|---|---|---|
| 6–35 mo | 0.25 | 1 or 2 |
| 3–8 y | 0.50 | 1 or 2 |
| ≥9 y | 0.50 | 1 |